Hybrid-modified poly(d,l-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 311-313

  Tahara, Kohei ^a,b   Furukawa, Sahori ^a   Yamamoto, Hiromitsu ^a   Kawashima, Yoshiaki ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Hybrid modification; Nanospheres; Poly(d,l lactide co glycolide); Poly l lysine; Polysorbate 80

Indexed keywords

LUCIFERASE; NANOSPHERE; PLASMID DNA; POLYGLACTIN; POLYLYSINE; POLYSORBATE 80; SOLVENT;

ARTICLE; CANCER CELL CULTURE; CELL TRANSPORT; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DIFFUSION; DISPERSION; EMULSION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DNA; DRUG CARRIERS; DRUG COMPOUNDING; GENE TRANSFER TECHNIQUES; HUMANS; LACTIC ACID; LUCIFERASES; NANOSPHERES; POLYGLYCOLIC ACID; POLYLYSINE; POLYSORBATES; SURFACE PROPERTIES;

EID: 77952711881     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.042     Document Type: Article

References (13)

1. Polymeric Gene Delivery: Principles and Applications 2005, CRC Press, Boca Raton, FL. M.M. Amiji (Ed.).
2. Hatakeyama H., Akita H., Kogure K., Oishi M., Nagasaki Y., Kihira Y., Ueno M., Kobayashi H., Kikuchi H., Harashima H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther. 2007, 14:68-77.
3. Kawashima Y., Yamamoto H., Takeuchi H., Hino T., Niwa T. Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur. J. Pharm. Biopharm. 1998, 45:41-48.
4. Kawashima Y., Yamamoto H., Takeuchi H., Kuno Y. Mucoadhesive dl-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm. Dev. Technol. 2000, 5:77-85.
5. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 2001, 47:65-81.
6. Lobenberg R., Araujo L., Kreuter J. Body distribution of azidothymidine bound to nanoparticles after oral administration. Eur. J. Pharm. Biopharm. 1997, 44:127-132.
7. Moret I., Esteban Peris J., Guillem V.M., Benet M., Revert F., Dasí F., Crespo A., Alino S.F. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. J. Control. Release 2001, 76:169-181.
8. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 24:329-347.
9. Tahara, K., Yamamoto, H., Kawashima, Y., 2010. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (d,l-lactide-co-glycolide) nanospheres for gene delivery. Eur. J. Pharm. Biopharm., in press.
10. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Hirashima N., Kawashima Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int. J. Pharm. 2009, 382:198-204.
11. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Kawashima Y. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int. J. Pharm. 2008, 354:210-216.
12. Tahara K., Yamamoto H., Takeuchi H., Kawashima Y. Development of gene delivery system using PLGA nanospheres. Yakugaku Zasshi 2007, 127:1541-1548. (Review, Japanese).
13. Yamamoto H., Kuno Y., Sugimoto S., Takeuchi H., Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J. Control. Release 2005, 102:373-381.